Clinical Report: The Current State and Future Outlook of the Physician-Scientist Pathway in Pediatric Rheumatology
Background
The formalization of pediatric rheumatology in North America in 1976 marked a significant milestone in the care of children with rheumatic diseases. Physician-scientists play a vital role in bridging clinical practice and research, yet the pathway to becoming one is increasingly challenging. The decline in interest in this career path poses challenges to the future of research and clinical advancements in pediatric rheumatology.
Data Highlights
No numerical data available in the source material.
Key Findings
Physician-scientists are defined as physicians dedicating over 50% of their efforts to biomedical research.
The pediatric rheumatology workforce is currently at 0.27 physicians per 100,000 children in the U.S.
As of June 2023, there are 508 board-certified pediatric rheumatologists aged ≤70 years.
88% of these pediatric rheumatologists hold faculty appointments at academic institutions.
Challenges in research training and academic advancement are contributing to a decline in the physician-scientist pipeline.
The aging workforce and predicted shortfall in pediatric rheumatologists threaten the future of the specialty.
Clinical Implications
Addressing the challenges in training and career development for physician-scientists is essential to ensure continued progress in the field.
Conclusion
The current state of the physician-scientist pathway in pediatric rheumatology reflects significant challenges.
